Yayi He

机构：Tongji University, Central South University, University of Electronic Science and Technology of China, Guangxi University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Fudan University, Cancer Institute (WIA), Peking University Cancer Hospital, Huadong Hospital, Nanjing Drum Tower Hospital, Shanghai Institute of Materia Medica, Peking University People's Hospital, Shanghai Pulmonary Hospital, Anhui Provincial Children's Hospital, Institute of Hematology & Blood Diseases Hospital, First People's Hospital of Chongqing, Helix (United States) · ORCID：0000-0002-2820-9119

发表论文 199 篇 · 总被引 6572 次 · h-index 38

代表论文

• Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer (2024 · Translational Oncology · 被引 15)
• Hepatic IκBζ promotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration (2025 · Free Radical Biology and Medicine · 被引 10)
• Integrative study of lung cancer adeno-to-squamous transition in EGFR TKI resistance identifies RAPGEF3 as a therapeutic target (2024 · National Science Review · 被引 9)
• Direct cGAMP Delivery via Iron Oxide Nanoparticles for Enhanced STING Activation and Durable Antitumor Immunity (2025 · Nano Letters · 被引 8)
• Expert consensus and current landscape of NUT carcinoma: A comprehensive strategy from diagnosis to treatment (2024 · Tumor Discovery · 被引 6)
• What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis (2024 · BMC Pulmonary Medicine · 被引 6)